Pediatric Clinical Trials Market
According to Intent Market Research, the Pediatric Clinical Trials Market is expected to grow from USD 2.4 Billion in 2024-e at a CAGR of 26.2% to touch USD 9.7 Billion by 2030. The Pediatric Clinical Trials Market is dominated by key players such as Novartis, Merck & Co., Inc., GlaxoSmithKline, AstraZeneca, Roche, and Johnson & Johnson